03.14.22 BioCentury: GreenLight messenger RNA shingles vaccine deal with Serum Institute of India Share: Share on Linkedin Share on Twitter Share on Facebook Agreement to manufacture and commercialize a messenger RNA shingles vaccine and two other RNA products. There is a high need for shingles vaccines in low- and middle- income countries where most people have not been vaccinated against chickenpox. Shingles is caused by reactivation of varicella zoster virus (VZV), which causes chickenpox; vaccination against chickenpox greatly reduces the risk of shingles. Read the full article here. Find out more about how GreenLight manufactures RNA.